COMPANY · NIPC 502155930

ZAMBON-PRODUTOS FARMACEUTICOS

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

614 contracts on Portal BASE, worth €11,631,017.67 in total.

Follow (RSS) · What is RSS?

Identification

Company nameZAMBON-PRODUTOS FARMACEUTICOS
NIPC502155930

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €288,265.3120122013: €208,115.042014: €160,907.0320142015: €306,041.532016: €355,83420162017: €470,236.122018: €400,826.7120182019: €964,370.042020: €637,228.1420202021: €461,011.762022: €753,544.3920222023: €2,034,470.042024: €1,898,281.8020242025: €1,734,262.882026: €957,622.882026€2,034,470.04
Contracted value by year
YearContractsContract value
20127€288,265.31
201314€208,115.04
20148€160,907.03
201531€306,041.53
201621€355,834
201720€470,236.12
201833€400,826.71
201939€964,370.04
202052€637,228.14
202140€461,011.76
202243€753,544.39
202365€2,034,470.04
202472€1,898,281.80
202584€1,734,262.88
202685€957,622.88
Contracted value by place of performance
NameContractsContract value
Setúbal40€3,304,277.75
Lisboa139€2,580,083.50
Funchal31€1,208,286.31
Faro34€955,793.84
Coimbra41€756,328.05
Vila Nova de Gaia28€593,571.36
Porto27€505,827.01
Évora8€276,568.07
Viseu22€250,876.91
Loures14€194,350.35
Largest contracts
SubjectYearContract value
VÁRIOS MEDICAMENTOS2024€689,293.50
Vários Medicamentos2023€685,492.31
41/272/2019 - Medicamentos Anti-Infecciosos2019€553,182.75
Aquisição de Medicamentos Antti infeciosos aq.2023/4922024€256,124.40
241G000174-COLISTIMETATO DE SODIO SOL P/ NEBULIZAÇÃO 1000000 UI (PROMIX2024€236,549.18

Who they competed with

In 1,057 contracts with a list of competitors, the company took part and was awarded 120 (11%).

Companies with the most procedures in common
CompanyProcedures in common
mylan69
Sandoz Farmacêutica, Lda.66
generis65
Overpharma-Produtos Médicos e Farmacêuticos, Lda62
labesfal,, SA58
Glaxosmithkline,Lda56
medinfar55
Teva Pharma - Produtos Farmacêuticos, Lda.47
Farmoz, S.A.42
Novartis Farma - Produtos Farmacêuticos, SA37
Unilfarma34
accord healthcare unipessoal, lda34
Bluepharma S.A.33
PFIZER32
Hikma Farmacêtica (Portugal), SA32
fresenius kabi pharma32
Ferraz Lynce, S.A.29
Pharmis Biofarmacêutica, Lda.26
dla sa26
B.Braun Medical, Unipessoal Lda.25
Astrazeneca - Produtos Farmacêuticos Lda.23
Laboratórios Atral, S.A.21
PLS Pharma, Produtos Farmacêuticos, Lda21
ratiopharm - Comércio Industria de Produtos Farmacêuticos, Lda.20
Cencora 3PL Portugal, S.A.20
Laboratórios Normon, SA20
Logista, Transportes, Transitários, e Pharma Unipessoal, Lda.19
Angelini Pharma Portugal, Unipessoal, Lda18
Merck, Sharp & Dohme, Lda.17
Pharmakern, Lda.16

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents40 companies and 60 links. The list below gives the same content as text.Novartis Farma… (NIPC 500063524)Novartis Farma…Ferraz Lynce, … (NIPC 500113270)Ferraz Lynce, …Glaxosmithklin… (NIPC 500139962)Glaxosmithklin…PFIZER (NIPC 500162166)PFIZERMerck, Sharp &… (NIPC 500191360)Merck, Sharp &…Unilfarma (NIPC 500293023)Unilfarmamedinfar (NIPC 500384045)medinfarAngelini Pharm… (NIPC 500583650)Angelini Pharm…labesfal,, SA (NIPC 501169580)labesfal,, SAB.Braun Medica… (NIPC 501506543)B.Braun Medica…NIPC 502155930 (NIPC 502155930)NIPC 502155930+29 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.